- Home
- Consulting Physician
- Trial on Xanomeline–Trospium in Patients with Schizophrenia
20213 min read
Medical Article
It is believed that almost 20 million people in the world at this moment are living with schizophrenia. This devastating mental health condition is associated with considerable disability and may affect educational and occupational performance. Despite more than a century of research, the precise cause of schizophrenia continues to elude investigat

Trial on Xanomeline–Trospium in Patients with Schizophrenia
Similar Content

Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments

Woman presented with Fever of Unknown Origin
7739 Reached93 Comments19 Likes

How Physicians Should Manage Stress?
35340 Reached151 Comments202 Likes

Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes

Male with Jaw Pain and Abdominal Bloating
790 Reached24 Comments26 Likes
